DiFCCA
![]() |
- $70 - $145
- Product name: DiFCCA
- CAS: 953905-51-6
- MF: C10H5F2NO2
- MW: 209.15
- EINECS:
- MDL Number:MFCD09734631
- Synonyms:2-Cyano-3-(2,4-difluorophenyl)-2-propenoic acid;DiFCCA;α-Cyano-2,4-difluorocinnamic acid;α-Cyano-o,p-difluorocinnamic acid;2-cyano-3-(2,4-difluorophenyl)acrylic acid;2-Propenoic acid, 2-cyano-3-(2,4-difluorophenyl)-;α-Cyano-2,4-difluorocinnamic acid
2 prices
Selected condition:
Brand
- Sigma-Aldrich
- TRC
Package
- 10mg
- 100mg
- ManufacturerSigma-Aldrich
- Product number77646
- Product descriptionα-Cyano-2,4-difluorocinnamic acid matrix substance for MALDI-MS, ≥95.0% (HPLC)
- Packaging100mg
- Price$145
- Updated2022-05-15
- Buy
- ManufacturerTRC
- Product numberC979565
- Product descriptionα-Cyano-2,4-difluorocinnamic acid
- Packaging10mg
- Price$70
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | 77646 | α-Cyano-2,4-difluorocinnamic acid matrix substance for MALDI-MS, ≥95.0% (HPLC) | 100mg | $145 | 2022-05-15 | Buy |
TRC | C979565 | α-Cyano-2,4-difluorocinnamic acid | 10mg | $70 | 2021-12-16 | Buy |
Properties
Melting point :>200o C (dec.)
Boiling point :326.1±42.0 °C(Predicted)
Density :1.461±0.06 g/cm3(Predicted)
storage temp. :Amber Vial, Refrigerator, Under inert atmosphere
solubility :methanol: soluble100mg/10 mL, clear, colorless to light yellow
pka :0.51±0.13(Predicted)
form :Solid
color :Pale Yellow
BRN :22870653
Boiling point :326.1±42.0 °C(Predicted)
Density :1.461±0.06 g/cm3(Predicted)
storage temp. :Amber Vial, Refrigerator, Under inert atmosphere
solubility :methanol: soluble100mg/10 mL, clear, colorless to light yellow
pka :0.51±0.13(Predicted)
form :Solid
color :Pale Yellow
BRN :22870653
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|